A detailed history of Aviso Financial Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Aviso Financial Inc. holds 965 shares of VRTX stock, worth $456,252. This represents 0.03% of its overall portfolio holdings.

Number of Shares
965
Holding current value
$456,252
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $379,061 - $468,536
965 New
965 $452 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Aviso Financial Inc. Portfolio

Follow Aviso Financial Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviso Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aviso Financial Inc. with notifications on news.